The Drug Development Letter
Substacknewsletter · by Vinay Prasad MD MPH · English
Dr Prasad currently works at the US FDA. The writings on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.
- Audience
- 10K subscribers
- Shown publicly on Substack
- Observed frequency
- No recent posts
- Observed from indexed posts
- Last post
- Aug 7, 2025
- Aug 7, 2025
- Likely audience
- Clinical researchers
- Inferred from post content
The Drug Development Letter is a Substack newsletter by Vinay Prasad MD MPH covering Clinical trial methodology, Informative censoring and Kaplan-Meier analysis. Its most recent indexed post is from Aug 7, 2025. Shown publicly on Substack: 10K subscribers.
Topics
- Clinical trial methodology
- Informative censoring
- Kaplan-Meier analysis
- Oncology treatment
- Exercise intervention
Recent posts
- Can I…
- The online…
- Does a…
- "LUNAR: Full…
- How to…
Sponsors detected
No sponsored posts detected in the last 180 days of indexed posts.
Detected automatically from posts marked as sponsored. Detection can miss or misread placements.
See the full picture on The Drug Development Letter
Subscriber momentum over time, every detected sponsor with the source post, companies and people it mentions, guests, and an alert when any of it changes.
The Drug Development Letter alternatives: similar newsletters
Ranked by how many topics they share with The Drug Development Letter.
- The Vajenda131K subscribers
SubstackWeekly · last post 2 days ago
Likely audience: Clinical researchers
1 shared topic
- Vinay Prasad's Observations and Thoughts54K subscribers
SubstackSeveral times a week · last post yesterday
Likely audience: oncologists
1 shared topic
- Surviving Healthcare54K subscribers
SubstackSeveral times a week · last post 4 days ago
Likely audience: Public health advocates
1 shared topic
SubstackWeekly · last post 11 days ago
Likely audience: Cardiologists
1 shared topic
LinkedInMonthly or less · last post 33 days ago
Likely audience: MedTech founders and executives
1 shared topic
SubstackMonthly or less · last post 38 days ago
Likely audience: Psychiatrists
1 shared topic
Compiled from public pages · refreshed Nov 3, 2026 · How NewsletterFIT collects and labels data